BXP vs CURX · rev $895.7M vs $8.9M cap
Boston Properties Inc (BXP) versus Curanex Pharmaceuticals Inc Common Stock (CURX) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Curanex Pharmaceuticals Inc Common Stock (CURX) is a biotechnology company listed on NASDAQ.
Latest reported BXP revenue for 2026-06-30 was $895.7M. Net income was $68.6M. Revenue was up 2.7% from 2026-03-31 to 2026-06-30. BXP currently screens at market cap $12.12B.
CURX does not have a complete income-statement cache yet.
BXP currently screens at market cap $12.12B. CURX currently screens at market cap $8.9M.
Not investment advice. Open the BXP and CURX stock pages for the full models.
Not investment advice.